Works matching IS 03407004 AND DT 2011 AND VI 60 AND IP 7
Results: 15
Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 1039, doi. 10.1007/s00262-011-1019-1
- By:
- Publication type:
- Article
Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8 T-cell-defined human tumor antigen of human carcinomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 919, doi. 10.1007/s00262-011-1001-y
- By:
- Publication type:
- Article
Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 931, doi. 10.1007/s00262-011-1002-x
- By:
- Publication type:
- Article
High susceptibility of c-KITCD34 precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line model.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 943, doi. 10.1007/s00262-011-1003-9
- By:
- Publication type:
- Article
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 953, doi. 10.1007/s00262-011-1004-8
- By:
- Publication type:
- Article
Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 965, doi. 10.1007/s00262-011-1007-5
- By:
- Publication type:
- Article
Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 975, doi. 10.1007/s00262-011-1010-x
- By:
- Publication type:
- Article
Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 985, doi. 10.1007/s00262-011-1009-3
- By:
- Publication type:
- Article
Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 999, doi. 10.1007/s00262-011-1005-7
- By:
- Publication type:
- Article
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 1009, doi. 10.1007/s00262-011-1014-6
- By:
- Publication type:
- Article
A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 1019, doi. 10.1007/s00262-011-1016-4
- By:
- Publication type:
- Article
Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 1029, doi. 10.1007/s00262-011-1015-5
- By:
- Publication type:
- Article
B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 1047, doi. 10.1007/s00262-011-1017-3
- By:
- Publication type:
- Article
Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 1057, doi. 10.1007/s00262-011-1031-5
- By:
- Publication type:
- Article
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 7, p. 909, doi. 10.1007/s00262-011-1046-y
- By:
- Publication type:
- Article